UltraThistle -- The World's Highest-Potency Milk Thistle Formula* Is Now Available Direct to You†
UltraThistle is prescribed by doctors because it is much more effective at reaching and protecting liver cells than any other milk thistle formula.
†Formerly available ONLY through medical doctors and other licensed healthcare professionals. UltraThistle is now available to the general public through LiverSupport.com.
Product Description
Medical
research indicates the active ingredient in UltraThistle is
better absorbed, and produces better results, than any other
silymarin or milk thistle extract. Additionally, this formula
is part of an ongoing hepatitis C treatment research study
at a foremost medical school AND a new hepatitis C dosing
study at a major university medical center. This scientific
validation explains why more and more doctors are prescribing
UltraThistle. And why more and more patients are choosing
it to protect and support thier liver.
To order UltraThistle, click here.
 I've been taking milk thistle products for several years now. A few years ago I discovered UltraThistle. Over these same years I've had regular lab work done in regard to my liver function. Even though I suffer from liver disease, my liver is functioning normally as has been documented by my lab work! I believe this is in a large part due to the UltraThistle I've been taking. - M. Miller
What is the evidence to support the claim that UltraThistle is significantly better?
This is the same question asked by doctors before giving UltraThistle their approval. Several human and animal studies have shown UltraThistle is dramatically better absorbed. In one study, the excretion of silybin in the bile was evaluated in patients undergoing gallbladder removal because of gallstones. A special drainage tube, the T-tube, was used to get the samples of bile necessary. Patients were given either a single dose of UltraThistle or silymarin. The amount of silybin recovered in the bile within 48 hours was 11% for the UltraThistle group and 3% for the silymarin group. This is nearly 4 times more in the bile.
In another study designed to assess absorption, plasma silybin levels were determined after administration of single oral doses of UltraThistle and a similar amount of silymarin to 9 healthy volunteers. The authors concluded UltaThistle was absorbed into the bloodstream roughly 8 times greater than regular milk thistle extracts standardized to contain 70-80% silymarin.
Top
What is the dosage recommendation for UltraThistle?
Based on the clinical study data, when maximum liver protection and support is needed, the dosage recommendation is 360mg three times per day. This is three capsules per day. One bottle of UltraThistle is a one month supply at the recommended dosage.
Top
Key Research
Several clinical studies have also
shown UltraThistle to produce better results than regular
silymarin extracts. In one study of 232 patients with chronic
hepatitis (viral, alcohol, or drug induced) treated with UltraThistle
at a dosage either 120mg twice daily or 120mg three times
daily for up to 120 days, liver function returned to normal
faster in the patients taking UltraThistle compared to a group
of controls (49 treated with a commercially available milk
thistle extract standardized to contain 70% silymarin; 117
untreated or given placebo).
Better results were also seen in a preliminary study in patients with chronic viral hepatitis (3 with hepatitis B, 3 with both hepatitis B and hepatitis C, and 2 with hepatitis C) given UltraThistle for 2 months. After Treatment, serum malondialdehyde levels (an indicator of lipid peroxidation) decreased by 36%, and the quantitative liver function evaluation, as expressed by galactose elimination capacity, increased by 15%. A statistically significant reduction of liver enzymes was also seen: AST decreased 17% and ALT decreased 16%.
In another study designed primarily to evaluate the dose-response relationship of UltraThistle, positive effects were again displayed at a level better than those reported for milk thistle extracts containing 70-80% silymarin. In the study, patients with chronic hepatitis due to either a virus or alcohol were given different doses of SILIPHOS®: 20 patients received 80mg twice daily, 20 patients received 120 mg twice daily, and 20 patients received 120mg three times daily for two weeks.
At all tested doses, UltaThistle produced a remarkable and statistically significant decrease of mean serum and total bilirubin levels. When used at the dose of 240 or 360mg per day, it also resulted in a remarkable and statistically significant decrease of the ALT and GGTP liver enzymes. These results indicate that even short-term treatment of viral or alcohol-induced hepatitis with relative low doses of phosphatidylcholine bound silymarin can be effective, but for the best results higher doses are indicated.
|
